v3.26.1
STATEMENTS OF NET ASSETS AVAILABLE FOR PLAN BENEFITS - Pfizer Savings Plan - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Investments, at fair value    
Total investments, at fair value $ 22,510,611 $ 20,301,844
Investments, at contract value    
T. Rowe Price Stable Value Fund 1,202,651 1,277,792
Total investments 23,713,262 21,579,635
Receivables    
Company contributions 380,090 386,799
Notes receivable from participants 101,255 107,179
Securities sold 1,970 0
Interest and other 3,030 2,727
Total receivables 486,345 496,705
Total assets 24,199,607 22,076,340
Liabilities    
Investment management fees payable 2,231 4,641
Payable to Plan Sponsor 302 4,072
Total liabilities 2,533 8,713
Net assets available for plan benefits 24,197,074 22,067,627
Pfizer Inc. common stock    
Investments, at fair value    
Total investments, at fair value 938,916 1,058,778
Common/collective trust funds    
Investments, at fair value    
Total investments, at fair value 18,660,013 16,252,996
Mutual funds    
Investments, at fair value    
Total investments, at fair value 566,228 838,470
Self-directed brokerage account    
Investments, at fair value    
Total investments, at fair value 487,501 408,798
Separate account    
Investments, at fair value    
Total investments, at fair value $ 1,857,953 $ 1,742,802